evaluate the digital health company rexmd on wegovy / semaglutide U.S. FDA | FDA has approved a new higher dose (7.2 mg) of ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight A big win for Wegovy:

Glutathione acts as a detoxifier, binding to harmful substances and facilitating their elimination through various bodily processes

The company has completed three studies and is conducting a fourth 90-day trial with 120 participants, but published data remains limited to company-run in-vitro assays, animal safety studies, and user testimonials

GLP-1 receptor agonists should not be combined with DPP-4 inhibitors as there is limited added benefit

Semaglutide offers powerful benefits for weight management, including effective appetite control that leads to sustainable weight loss

According to Ruder, GLP-1 also has other effects that we are only beginning to understand, and the exact mechanism for weight loss is not yet completely understood